

The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News

TEQ103, a novel therapeutic for the treatment of estrogen receptor alpha positive (ERα+) breast cancer
These results demonstrate the significant durable antitumor effect of TEQ103 driven by the total dose administered. Read the poster!

Metastasis Development Induced by Intracarotid Injection
We show a new TNBC mouse model of brain metastasis, induced by intracarotid injection, while assessing BBB integrity. Read the poster!

Novel PSMA+ and FAP+ mouse models
We designed new mouse models, which could aid in the development of novel imaging or radiotherapy agents for two biomarkers. Read the poster!

Pharmacological evaluation using the AbYlink TM regio-selective conjugation technology
AbYlink is a regio-selective labeling method, enabling a one-step conjugation of payloads to the Fc domain of an antibody. Read the poster!

PDX-Derived Organoids: Insights into Cancer Stem Cells and Metastasis
Our study highlights the versatility and translational relevance of PDXOs in cancer research. Read the poster!

Debiopharm and Oncodesign Services Launch Strategic Collaboration
Debiopharm and Oncodesign Services announce the execution of a license agreement for the use of the AbYlink technology

Radioligand Binding Assays: A Lost Art in Drug Discovery?
Old-school or still essential? Explore the overlooked power of radioligand binding assays in today's research environment.

Webinar – Hidden Potential: Using Fragments to Uncover New Ligandable Sites on Popular Targets
Learn how fragments reveal novel opportunities in well-known drug targets. Watch the webinar to explore strategies, case studies, and actionable insights.

White Paper: Discovering & Advancing Molecular Glues Using a Cooperativity-Based Approach
Discover how a cooperativity-driven approach accelerates molecular glue discovery. Download the white paper to learn more about the science and strategy.

PDX Research Model Guide
Explore 200+ PDX models across 14 indications. Better predict clinical response with fully characterized, customizable models. Download now.

Oncodesign Services appoints Aidan Synnott as CEO to enhance strategic drug discovery partnerships
Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery.

Publication: The Nature of Nanodisc Lipids Influences Fragment-Based Drug Discovery Results
Discover how nanodisc lipids impact fragment-based drug discovery, enhancing membrane protein screening and enabling new therapeutic possibilities.